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Ultra high-field 7T MRI offers sensitivity to localize hippocampal pathology in temporal lobe 
epilepsy (TLE), but has rarely been evaluated in patients with normal-appearing clinical 
MRI. We applied multimodal 7T MRI to assess if focal subfield atrophy and deviations in 
brain metabolites characterize epileptic hippocampi. Twelve pre-surgical TLE patients (7 
MRI-negative) and age-matched healthy volunteers were scanned at 7T. Hippocampal 
subfields were manually segmented from 600μm isotropic resolution susceptibility-
weighted images. Hippocampal metabolite spectra were acquired to determine absolute 
concentrations of glutamate, glutamine, myo-inositol, NAA, creatine and choline. We 
performed case-controls analyses, using permutation testing, to identify abnormalities in 
hippocampal imaging measures in individual patients, for evaluation against clinical 
evidence of seizure lateralisation and neuropsychological memory test scores. Volume 
analyses identified hippocampal subfield atrophy in 9 / 12 patients (75%), commonly 
affecting CA3. 7 / 8 patients had altered metabolite concentrations, most showing reduced 
glutamine levels (62.5%). However, neither volume nor metabolite deviations consistently 
lateralized the epileptogenic hippocampus. Rather, lower subiculum volumes and 
glutamine concentrations correlated with impaired verbal memory performance. 
Hippocampal subfield and metabolic abnormalities detected at 7T appear to reflect 
pathophysiological processes beyond epileptogenesis. Despite limited diagnostic 
contributions, these markers show promise to help elucidate mnemonic processing in TLE.
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Introduction 
Clinical imaging investigations in drug-resistant temporal lobe epilepsy (TLE) aim to detect 
seizure foci arising from surgically targetable lesions, the most common of which is 
hippocampal sclerosis (HS). The presence of HS on diagnostic imaging offers a prognostic 
marker for surgical treatment success in TLE 1,2. The complex and heterogeneous 
architecture of the hippocampus, however, hinders detection of cell loss that may 
differentially affect specific hippocampal subfields across patients 3. 
 
High-field 7T MRI provides enhanced contrast relative to standard (1.5 or 3T) clinical MRI 
systems, alongside exquisite spatial detail due to increased signal-to-noise yield 4. 
Consequently, 7T MRI offers potential to identify hippocampal lesions that go undetected 
in around 20% of routine TLE clinical scans. In people with focal epilepsy, initial 7T studies 
have demonstrated sensitivity to detect tuberous sclerosis lesions 5, polymicrogyria 6, focal 
cortical dysplasia 7-9, and hippocampal sclerosis 9-12. Compared to clinical MRIs, 7T 
anatomical imaging enables improved qualitative 9,11 and quantitative 10,12 hippocampal 
atrophy ratings for TLE patients with known pathology. But to provide added value, 7T 
must show enhanced sensitivity to pathology not evidenced on clinical MRI that, 
furthermore, improves treatment outcome predictions in individual patients. Yet, in the only 
prior study of patients with normal clinical imaging, 7T hippocampal volumetry showed no 
association with post-operative seizure outcomes 12. 
 
Despite the predictive association between HS and surgical outcomes in TLE, the 
relationship between seizure activity and neuronal atrophy remains elusive 13. In 10-30% of 
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surgically resected epileptic hippocampi, no features of sclerosis are identified on 
pathological examination 3,14. In those patients whose diagnostic MRI scans appear normal 
(so-called ‘MRI-negative’ TLE patients), measures of tissue metabolism may instead 
identify hippocampal dysfunction informative for surgical selection. Non-invasive MRI 
spectroscopy (MRS), in particular, enables quantification of concentrations for a range of 
brain metabolites that may inform specific pathophysiological processes in TLE. The 
majority of MRS studies have focused on N-acetyl-aspartate (NAA), reductions in which 
have proven informative to detect neuronal dysfunction even in TLE patients with normal-
appearing MRI (e.g. 15-18). Because unbalanced excitatory and inhibitory conductance is 
implicated in epileptogenesis 19, quantifying levels of excitatory hippocampal glutamate and 
inhibitory GABA neurotransmitters has become increasingly important in TLE 20. 
Microdialysis studies have uncovered increased glutamate levels from epileptic 
hippocampi even in the interictal state 21,22. However, measuring concentrations of 
glutamate and related metabolites (glutamine, GABA) non-invasively using MRS poses 
significant technical challenges due to the distribution of their spectral peaks across 
several resonance frequencies, which, furthermore, overlap with those of other 
metabolites. Due to the increased signal-to-noise and spectral resolution afforded by ultra-
high field imaging, these, among 15 neurochemicals, have now become quantifiable at 7T 
23. 
 
Here, we performed a multimodal imaging study at 7T in 12 pre-surgical TLE patients and 
age-matched healthy controls. Our aim was to quantify hippocampal neurochemical 
concentrations, as well as hippocampal subfield volumes from ultra-high (600μm) 
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resolution susceptibility-weighted anatomical scans acquired in pre-surgical TLE patients 
with either clinically-reported atrophy or normal-appearing MRI. T2* susceptibility effects 
are pronounced at ultra high field strength, providing novel, exquisite contrast to the 
internal architecture of the hippocampus 24,25. We extended conventional group-level 
comparisons with individual patient-control analyses to evaluate whether neurochemical 
abnormalities and focal hippocampal subfield atrophy quantified at 7T provide lateralizing 
data, especially in TLE patients with normal-appearing MRI. 
 
Results 
Hippocampal sub-region atrophy 
Patient clinical and demographic data are presented in Table 1. To evaluate whether 
hippocampal subfield volumes differed between our TLE patients and age-matched healthy 
controls, we performed manual segmentations as previously described 26 of the CA1, CA2, 
CA3 and dentate gyrus subfields on ultra-high resolution (600μm isotropic) susceptibility 
weighted imaging (SWI) scans acquired at 7T. Due to artifacts in the SWI scans (see 
Methods and Supplementary Fig. S1 online), segmentations could not be performed in one 
control and were excluded for the left hemisphere of one patient. At the group-level, 
analyses of covariance, adjusting for age, revealed significantly reduced left hemisphere 
CA3 (F = 6.35, p = 0.021) and subiculum (F = 4.92, p = 0.040) volumes in TLE patients 
versus controls (Fig. 1, Supplementary Table S1 online). 
 
To further determine if ultra-high field imaging identified localized subfield atrophy 
consistent with atypical HS not detected on diagnostic clinical imaging, we evaluated each 
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individual patient’s volumetric measurements against the group of controls through case-
control permutation tests using PALM (https://fsl.fmrib.ox.ac.uk/fsl/fslwiki/PALM). In order 
to increase the number of permutations possible to enable single case-control analyses 
with small sample sizes, permutations were performed with sign flipping 27. At the 
individual level, permutation tests identified altered subfield measures in 9 patients and 
trends in a further 2. Selected cases are illustrated in Figure 2. Among the 4 patients with 
established radiological evidence of HS on clinical MRI, 7T subfield findings were 
concordant in 3 patients (Cases 7, 12 and 6) and uninformative (i.e. normal) in Case 3. A 
further 4 patients had equivocal clinical MRI but lateralizing PET abnormalities. In these 4 
patients, subfield results identified bilateral pathology consistent with confirmed bilateral 
seizure onset in Case 2, but were discordant with seizure and PET lateralization in Cases 
11, 1, 10. Finally, among the 3 patients with normal diagnostic (MRI + PET) imaging, 
subfield data were concordant with EEG lateralization in Case 9, discordant in Case 4 and 
uninformative in Case 8 (Table 2). 
 
Metabolite concentrations 
We next determined whether metabolite quantification at 7T from left and right 
hippocampal voxels of interest (VOIs) would identify systematic abnormalities in 
hippocampal tissue function in TLE patients compared to healthy controls. Concentrations 
of total NAA, glutamate, glutamine, total choline, total creatine, and myo-inositol were 
measured in 8 / 11 patients and 12 controls, after data were discarded from 3 patients due 
to lipid contamination. GABA and lactate concentrations could not be reliably quantified 
and were excluded from analysis (described in Methods, below). As a group, TLE patients 
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showed reduced total NAA levels in both hippocampi (left F = 6.88, p = 0.018; right F = 
13.7, p = 0.002, analyses of covariance, correcting for age) relative to controls (Fig. 3, 
Supplementary Table S2 online). Other metabolites did not differ between patients and 
controls when considered at the group level. 
 
When compared individually to the group of controls, case-control analyses revealed 
altered metabolite concentrations in 6 patients and asymmetry in a 7th, out of the 8 patients 
with MRS data. Metabolite differences were concordant with radiological HS in Case 7, but 
bilateral in Cases 5 and 12. Among the 5 patients who had equivocal clinical MRI, Case 11 
had normal metabolite concentrations. The remaining four patients showed neurochemical 
abnormalities bilaterally (Cases 9 & 10), contralaterally (Case 8) or within the presumed 
epileptic hippocampus (Case 4). Illustrative individual results are presented in Figure 4. 
The individual metabolites affected in each patient are listed in Table 2. In addition to total 
NAA, altered metabolite concentrations were detected for glutamine (n=5), total choline 
(n=3), total creatine (n=3), myo-inositol (n=2), and glutamate (n=2). No single metabolite 
provided greater correspondence to clinical imaging and / or EEG than others. 
 
Associations with epilepsy and memory performance  
Atrophy of specific hippocampal subfields correlated with clinical disease variables. 
Younger age at onset of seizures was associated with smaller volumes in ipsilateral CA1 
(R = 0.69, p = 0.018) and DG (R = 0.67, p = 0.023) (Fig. 5). Accounting for age, longer 
epilepsy duration correlated with smaller ipsilateral (CA1, DG, subiculum) and contralateral 
(CA1, CA2) volumes. Metabolite concentrations showed no such correlations.  
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Furthermore, in patients, both volumetric and metabolic hippocampal measurements 
correlated with clinical neuropsychological measures of verbal memory performance. 
Specifically, smaller subiculum volumes in the language-dominant hemisphere correlated 
with lower delayed story recall scores (R = 0.62, p = 0.020, one-tailed) (Fig. 6) whereas 
lower left hippocampal glutamine concentrations correlated with reduced list learning (R = 
0.79, p = 0.017, two tailed). No associations were found between visuospatial memory and 
right hippocampal imaging measures. 
 
Discussion 
The strong predictive association between HS and surgical seizure control in drug-resistant 
TLE patients 1,2 has spurred growing research into the potential of ultra-high resolution MRI 
to identify pathology not detected at routine clinical field strengths. Accumulating data 
highlight the increased discernibility at 7T of known epileptogenic lesions 5-11. The ability of 
7T to newly identify lesions in patients with ‘normal appearing’ clinical MRI, however, has 
only rarely been assessed 12. Our aims were to test whether quantification of subfield 
volumes and metabolite concentrations at 7T aids in lateralizing hippocampal dysfunction 
in TLE patients with normal appearing as well as radiologically atrophic hippocampi. 
Analysis of hippocampal subfield volumes, measured from ultra-high resolution 7T scans, 
revealed atrophy generally concordant with radiological diagnoses of HS, but provided 
additional information in only 1 TLE patient (14%) with equivocal clinical imaging. 
Complementary 7T hippocampal MRS revealed neurochemical disruption in 87% of 
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patients, which was not, however, specific to the side of ictal EEG onset in either 
radiological HS or MRI-negative patients. 
 
Three prominent patterns of HS are recognized histopathologically. The most common 
(Type 1) is characterized by extensive cell loss affecting CA1, CA3 and CA4, while atypical 
variants more selectively affect CA1 (Type 2) or CA4 (Type 3)3. Both atypical forms are 
associated with poorer long-term surgical seizure control than classical HS 13. Detailed pre-
operative anatomical stratification of radiological hippocampal atrophy patterns could, 
therefore, potentially facilitate surgical decision-making. However, atypical CA1- and CA4-
‘predominant’ HS is commonly missed on pre-operative clinical MRI 28. 
 
Studies conducted to date in TLE patients with a presumed hippocampal focus advocate 
the sensitivity of ultra-high resolution 7T T2 and T2*-weighted scans to uncover variations 
in subfield atrophy among patients with established radiological diagnoses of HS 10,11. In 
contrast, the only prior in vivo 7T study to evaluate subfield volumes in TLE patients with 
normal-appearing MRI identified abnormalities in only 3 / 9 MRI-negative patients 12, and 
these showed no relationship to surgical outcome. In that study, hippocampal subfield 
volumes were quantified only from the body of the hippocampus, which may have 
underestimated localized pathology. Here, we extended subfield quantifications to the full 
length of the hippocampus and confirmed that 7T subfield volumetry clearly distinguished 
widespread from focal atrophy. Subfield atrophy ranged from none to widespread in our 
patients with radiologically indicated HS, while patients with normal-appearing clinical MRI 
showed subfield loss focused on CA3, and, in one case, CA1. Longer disease duration 
  10
correlated with greater subfield atrophy especially in bilateral CA1 and ipsilateral DG and 
subiculum, consistent with prior reports highlighting a link between hippocampal atrophy on 
MRI and clinical factors including epilepsy duration and, potentially, severity (see 3). 
However, patterns of hippocampal subfield atrophy showed limited correspondence to pre-
operative seizure lateralization in our series. In 3 / 4 patients who underwent a unilateral 
amygdalo-hippocampectomy and remained seizure-free one year following amygdalo-
hippocampectomy (Table 1), pre-operative 7T localized atrophy to the contralateral 
hippocampus. Therefore, while greater subfield volume loss in the context of longer 
histories of chronic epilepsy support progressive seizure-related degeneration 29-31, the 
presence or absence of 7T subfield atrophy alone was in general neither a sufficient, nor a 
strong, indicator of the laterality of seizure onset. 
 
In contrast, subfield volumetry was potentially informative in two patients. Exclusively 
contralateral hippocampal atrophy was detected in one patient not rendered seizure-free 
by surgery, although a sub-complete resection cannot be ruled out. In the second case, 
bilateral subfield atrophy was detected in a MRI-negative patient with subsequently 
confirmed bilateral independent seizure onset. 7T imaging has previously shown 
heightened sensitivity to detect bilateral abnormalities in other epileptic syndromes 
including polymicrogria 6. Since the presence of widespread abnormalities reduces the 
chance of successful surgical seizure control, 7T evidence of contralateral hippocampal 
damage may help identify patients who are less likely to benefit from surgery. Caution, 
however, is clearly warranted when interpreting 7T volumetry to inform surgical or 
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intracranial EEG candidate selection, because of the lack of direct link between neuronal 
loss and seizure lateralization.  
 
TLE patients without any histological features of HS may nonetheless experience 
significant benefit from surgical intervention. In epilepsy, a leading hypothesis is that the 
balance between excitatory and inhibitory neurotransmission is unsettled 19 due to a 
disruption in the glutamate-glutamine-GABA cycle 21. Methods able to quantify such 
metabolic imbalances may, therefore, help localize surgical targets in MRI-negative 
epilepsies 32. To our knowledge, a comprehensive quantification of hippocampal metabolite 
concentrations detectable at 7T, and their complement to subfield volumetry as a means to 
lateralize TLE has not previously been described. 
 
In our patient group, ultra-high field 7T hippocampal MRS identified bilaterally reduced total 
NAA at the group-level and decreased glutamine concentrations in 5 / 8 patients. 
Reductions in total NAA and NAA / Cr ratios are well established in TLE and have been 
reported to show sensitivity to hippocampal dysfunction even in patients with normal-
appearing MRI (e.g. 15,16,33). Despite their sensitivity, NAA abnormalities are not always 
lateralizing (e.g. 34) and are known to extend contralaterally 15,16,33. Widespread NAA 
reductions, furthermore, reportedly revert to normal levels following successful surgical 
treatment 35,36, limiting their specificity for seizure localization.  
 
In contrast to well-characterized NAA abnormalities, glutamine and glutamate 
concentrations have rarely been independently quantified in TLE due to methodological 
  12
difficulties in resolving these metabolites at clinical field strengths. Using a sequence 
specifically tailored to detect glutamate, a recent 7T study uncovered asymmetric 
hippocampal glutamate levels in four TLE patients with normal appearing MRI, driven by 
heightened signal in the hippocampus associated with seizure onset 20. We did not find 
systematic increases in hippocampal glutamate concentrations in our TLE group. A likely 
source for this disparity is our use of single voxel MRS. Indeed, using a high spatial 
resolution whole-brain slice approach, Davis and colleagues identified heterogeneity in 
glutamate concentrations along the anterior-posterior length of the hippocampus, with 
elevated glutamate signal arising specifically from the head of the hippocampus 20. Due to 
the angulation of the hippocampus and to minimize amygdalar tissue inclusion, we 
positioned MRS voxels predominantly over the body of the hippocampus, which likely 
diluted sensitivity to heightened anterior hippocampal glutamate levels.  
 
In our TLE patients, a most common, though variable, metabolic imbalance was a 
reduction in hippocampal glutamine concentrations. While this finding could theoretically 
provide a marker of deficient glutamine synthesase, recent microdialysis recordings from 
41 hippocampal sites in surgical epilepsy candidates unexpectedly revealed no difference 
in interictal glutamine levels between epileptogenic and non-epileptogenic locations 22. The 
possible mechanisms and clinical significance of our observed deviations in interictal 
hippocampal glutamine concentrations in some TLE patients, therefore, is currently 
unknown. Due to high estimation errors, we were unable to accurately quantify GABA 
levels from our hippocampal VOIs at 7T. This technical limitation highlights amplified 
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shimming-related challenges for ultra-high field medial temporal lobe MRS that may be 
potentially easier to overcome on advanced 3T systems. 
 
The high sensitivity of ultra-high field imaging offers the prospect of generating 
pathophysiological signatures of individual patients’ unique interictal landscape. Because 
of substantial variability in deviations of other metabolite levels (namely total choline and 
myo-inositol) among our patients, we were not able in this study to clarify the mechanistic 
role of these metabolite abnormalities in chronic TLE. Importantly, however, 
neurometabolite levels measured from 7T hippocampal MRS in our patients showed no 
consistent correspondence to side of ictal onset. 
 
The hippocampus is known to play a critical role in aspects of memory formation. The 
specific computations performed by individual subfields, however, remain the subject of 
active investigation 37,38. Previous studies that linked histopathological atrophy patterns to 
memory skills produced mixed findings. While some reported links between (typically 
verbal) memory decline and dentate gyrus, but not CA1 cell counts 39, others found no 
unique correlations between memory performance and individual subfields 40,41. We 
explored whether reduced hippocampal subfield volumes and altered metabolite levels, 
which were not strongly indicative of side of seizure onset, instead indexed memory 
function in our TLE patients. Given the heterogeneity in hippocampal subfield atrophy 
across our HS and normal-appearing patients, the absence of CA subfield and DG 
associations with verbal memory function in our TLE group is not surprising. Yet, despite 
our limited sample size, we observed an association between subiculum volume in the 
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language-dominant hemisphere and story recall performance. While subicular neuronal 
volumes are generally relatively preserved in TLE 42,43, it has been proposed that subicular 
cells may be selectively vulnerable to secondarily generalized seizures 44. Disruption of the 
subiculum and its major cortical projections, therefore, offers a mechanism for dysfunction 
of the hippocampal-cortical functional circuitry. Consistent with this idea, it is interesting to 
note that subiculum neuronal cell counts (indexed by MAP2 labeling) were recently found 
to be the only predictor of naming declines one year after TLE surgery 41. 
 
The subiculum has also been proposed as a potential generator of interictal discharges in 
cell recordings of resected TLE hippocampal tissue 45,46. Interictal discharge activity 
directly contributes to memory disruption in TLE 47 and poses an important confound in 
evaluations aiming to predict surgical memory outcomes from pre-operative performance. 
Our data linking subicular volume loss with impaired preoperative story recall may 
potentially offer an additional means to discriminate transient interictal discharge effects 
from likely irreversible network disruption in surgical TLE candidates. 
 
Limitations of this study include our small sample size. Sample sizes of between 6 and 13 
are characteristic of contemporary 7T epilepsy patient studies, and reflect the cost and 
challenges of ultra-high field imaging. The stringent contraindication of relatively frequent 
metallic implants and prior surgical procedures pose a particular recruitment challenge in 
patients with seizure disorders. We intentionally included TLE patients with complex and 
ambiguous clinical findings in order to capture those scenarios in which 7T may 
theoretically be most useful. It was therefore possible from the outset that hippocampal 
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imaging would not detect any abnormalities and yield less sensitivity than prior HS-focused 
studies. However, among the largest reported series of epilepsy patients to date, visual 
ratings of extensive 7T imaging also did not provide enhanced discrimination in 19 patients 
with presumed focal cortical dysplasia or mesial temporal sclerosis and equivocal 3T MRI. 
Additional limitations include our low number (n = 5) of patients with confirmatory surgical 
outcomes. Following intracranial investigations, two patients were deemed unsuitable for 
surgery. One patient declined surgery; one patient declined depth recordings; and two 
require further investigations to better localize the ictal focus. One additional patient has 
been operated and is pending clinical follow-up. Finally, owing to selective amygdalo-
hippocampectomy being the preferred resection method at our center, comprehensive 
histopathological analysis of resected tissue was precluded. While daily quality assurance 
scans were performed to ensure stability in the scanner software and hardware over time, 
we could not assess scan-rescan reliability from our single measurements. Test-retest data 
will be important in future studies to ascertain the impact of between-session variability on 
hippocampal subfield volumetry measurements. 
 
In conclusion, our data indicate high sensitivity but large individual variability in the 
accuracy with which 7T hippocampal subfield atrophy and metabolic dysfunction lateralize 
the side of seizure focus in TLE. Neither hippocampal volumetric nor spectroscopic 7T 
measurements provided a robust predictor of seizure lateralization when assessed against 
post-operative seizure control. Instead, correlations with memory performance indicate a 
potential contribution of 7T hippocampal imaging in clarifying the wider impact of chronic 




Twelve pre-surgical patients aged 35.2 ± 10.3 years (range 19 – 57, 7 men) with 
suspected medial temporal lobe epilepsy (TLE) were prospectively recruited through the 
Oxford Epilepsy Surgery Programme (Table 1). The sample size was informed by clinical 
throughput and those selected for the study were a representative population of patients 
being considered for selective amygdalo-hippocampectomy. Patients were eligible for the 
study if they had seizures suspected to arise from mesial temporal structures based on 
comprehensive multidisciplinary clinical assessment, and were under consideration for 
epilepsy surgery. A consultant neuroradiologist specialized in epilepsy reported clinical 
scans, which revealed features consistent with hippocampal sclerosis (HS) in 5 patients 
and normal or equivocal findings in 7 patients. Three patients required depth electrode 
recordings (after all other investigations, including research 7T MRI, was complete), due to 
uncertainty in the hemispheric lateralization or location of seizure onset within the temporal 
lobe (Table 1). All patients were receiving combination anti-epileptic drug therapy. Controls 
were 12 healthy volunteers with no neurological or psychiatric history, age-matched to 
patients (mean 29.5 ± 10.3 years, range: 22 – 60, 3 men, independent samples t-test p = 
0.191). Written informed consent was obtained from all participants in accordance with the 
principles of the Declaration of Helsinki. The study was approved by the South London 
Research Ethics Committee. 
 
Neuropsychology 
Each patient underwent comprehensive neuropsychological assessment as part of their 
surgical evaluation, including test of verbal and non-verbal memory abilities from the Brain 
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Injury Rehabilitation Trust Memory and Information Processing Battery (BMIPB). From this 
battery, we selected list learning and delayed story recall performance to assess verbal 
memory and retention, and design learning and figure recall scores to assess non-verbal 
memory abilities in patients. 
 
MRI 
Data were acquired on a 7 Tesla Siemens MRI system, using a 32-channel head coil at the 
University of Oxford FMRIB Centre. Barium titrate pads positioned over the temporal bone 
were used to increase the extent of the effective transmit field (B1+). A whole brain T1-
weighted anatomical scan was acquired to inform hippocampal slice angulation and MRS 
voxel placement. 
 
Susceptibility-weighted imaging (SWI) 
Hippocampal volumetry studies have typically been based on T2 weighted scans that are 
readily available on clinical MRI systems. With the development of 7 Tesla human MRI 
scanners, research has focused on utilizing the advantages of higher field strengths to 
develop optimized and novel signal contrasts that can be exploited for the detection of 
pathology not easily seen at clinical field strengths. T2* susceptibility effects, in particular, 
are more pronounced at higher field strengths, providing exquisite contrast to the complex 
internal structure of the hippocampus 24,25. Such contrast and high spatial detail can be 
obtained without the higher power deposition that limits spin-echo based T2 sequences 48. 
The origin of the improved contrast remains uncertain, but the larger susceptibility effects 
have been proposed to reflect variations in iron content between hippocampal subregions 
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49, as well as differences in subregion tissue cellularity and microvasculature 25. 
Consequently, the majority of previous 7T studies in epilepsy patients have utilized T2*-
weighted contrast to investigate hippocampal atrophy. For consistency with prior studies 
and to harness the advantages of 7T, SWI sequences were collected for manual volumetry 
in all 12 patients and 11 / 12 healthy controls using the following parameters: TE = 25.7ms; 
TR = 50ms; voxel size = 0.6 × 0.6 × 0.6mm; partial Fourier = 6/8; FOV = 192mm, 44 slices, 
flow compensation, duration 05:35 minutes. In the 12th control, the SWI scan was acquired 
at higher resolution, affecting segmentation consistency. This control was therefore omitted 
from volumetric analyses. Slices were aligned perpendicular to the main axis of the 
hippocampus for optimal subfield visualization (Fig. 1). SWI scans were acquired twice in 
all participants, in left-to-right and in right-to-left phase acquisitions. The single best 
acquisition was selected for manual segmentation in each participant (detailed below). 
 
Magnetic Resonance Spectroscopy (MRS) 
Single-voxel MRS data were acquired in 11 patients and all 12 controls from a 3.36 mL (10 
× 12 × 28 mm3) voxel region of interest (VOI) placed over each hippocampus. Voxels were 
carefully positioned to encompass the head and body of the hippocampus while minimizing 
partial volume contributions from adjacent voxels anteriorly in the amygdala and laterally in 
the temporal horn and white matter. First and second-order shims were adjusted by 
gradient-echo shimming, after which first-order shims were fine-tuned using FASTMAP. 
Spectra were measured with a using a semi-LASER pulse sequence (TR=6ms, TE=36ms) 
with VAPOR (variable power and optimized relaxation delays) water and outer volume 
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suppression. In total, 112 averages (duration: 11:12 minutes) were measured separately 
from the left and right hippocampi. 
 
Manual segmentation of hippocampal subregions 
Hippocampal subfield volumes were calculated from manual segmentations of CA1, CA2, 
CA3, DG and subiculum (see 26), blinded to clinical results (Fig. 1). Hippocampal 
subregions were manually delineated on individual subjects’ ultra-high resolution SWIs 
using ITK-SNAP (www.itksnap.org). Due to variable degrees of image quality and signal 
dropout, manual segmentations were performed on the single SWI image that provided the 
best signal–to–noise in each participant. As described previously 26, the hippocampus was 
subdivided into CA1, CA2, CA3, DG and subiculum based on a consensus 7T protocol 50,51 
with reference to previous literature 52-54. Signal dropout in the medial temporal lobe 
precluded manual segmentation in one hemisphere of one patient and both hemispheres 
of one healthy control (Supplementary Fig. S4 online). These data points were therefore 
excluded from volumetric analyses. Analyses were performed on the data for the 
remaining n=10 controls as well as the right hemisphere data for 12 patients and left 
hemisphere data for 11 patients. 
 
Hippocampal subfield volumes were corrected for differences in head size using a 
covariance correction method 55. First, the slope of the regression line between total 
hippocampal volume and total brain volume (measured using FSL FAST) was calculated in 
a larger group of 25 previously reported healthy volunteers, scanned on the same 7T 
scanner using the same SWI sequence 26. Regression lines were calculated separately for 
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female and male controls, and for the left and right hippocampus. The computed gradient 
between total hippocampal and total brain volumes from this independent group of controls 
was then applied to calculate corrected hippocampal volumes for all participant in this 
study using the equation: Adjusted Volume = Observed Volume – Slope (TBVsubject - 
TBVmean), where TBVsubject is the total brain volume for the given participant, and TBVmean is 
the average total brain for the healthy controls. We then, secondly, determined the scaling 
factor to apply to individual subfield volumes. We divided the observed total hippocampal 
volume by the adjusted hippocampal volume for each participant, and multiplied each 
participant’s subfield volumes by this resulting unique scaling factor to obtain head-size 
adjusted subfield volumes. 
 
To determine the reliability of manual hippocampal subfield segmentations, segmentations 
in 5 randomly selected healthy controls were performed twice, at least 6 months apart. A 
repeated-measures ANOVA across all subregion volumes showed no significant effect of 
time (F= 0.0005, p = 0.98) or interaction between subregion volume estimate and time (F = 
0.52, p = 0.72). The intra-class correlation coefficient showed good intra-rater reliability for 
manually defined volumes, with a mean CI of 0.78 and average 95% confidence interval 
0.27-0.97). Only CA2 showed variable segmentation reliability, consistent with prior reports 
highlighting the greater difficulty in defining the borders of this small subregion (56, 51). 
 
MRS processing and quantification 
Individual spectra were phase and frequency corrected. As previously described 57, two 
non-suppressed water spectra were acquired: one for eddy current correction and 
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reconstruction of the phased array spectra (the RF pulses of the VAPOR scheme were 
turned off) and one for use as a reference for metabolite quantification (VAPOR and OVS 
schemes turned off in order to eliminate magnetization transfer effects). Single scan 
spectra from 32 channels were corrected for frequency and phase variations induced by 
subject motion and then summed. 
 
Metabolite concentrations for total N-acetylaspartate, glutamate, glutamine, total Choline, 
total creatine, GABA, lactate, and myo-inositol were estimated using LCModel 58, using the 
unsuppressed water signal as internal reference. To remove the potential impact of 
cerebrospinal fluid (CSF) on the metabolite concentration estimates, CSF correction was 
performed on both VOIs. A binary mask of the VOI location was constructed in the same 
imaging matrix as the T1 structural image and applied to a manual whole-hippocampus 
segmentation to calculate the voxel grey matter, white matter and CSF fractions within 
each VOI. Metabolite concentrations were then corrected for the CSF fraction (FCSF) by 
multiplying the measured values by [1/(1–FCSF)](LCModel manual).  
 
Metabolites quantified with Cramer-Rao Lower Bounds >50% were considered not reliably 
detected. On this basis, GABA and lactate were rejected for analysis. For all reported 
metabolites, CRLBs were ≤ 25% for every participant, in both hippocampi. Due to lipid 
contamination, data from 3 patients were excluded from metabolite analysis (leaving n = 8 
TLE patients and n=12 controls). 
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Signal intensity peaks reflecting metabolite concentrations are typically expressed as ratios 
normalized to creatine, levels of which are assumed to be homogeneous across brain 
tissue. However, prior studies in TLE patients identify potential abnormalities in creatine 
levels within epileptic hippocampi, with reports of increases 59, reductions 34 and normal 
levels 16 in epilepsy sub-types compared to controls. In our analyses, we therefore, 
focused on absolute metabolite concentrations. 
 
Asymmetry calculations 
An asymmetry index was calculated for each hippocampal sub-region and each metabolite 
using the equation (L - R) / [(L + R)/2], where L is the volume or metabolite concentration 
from the left hippocampus and R represents the equivalent measure quantified from the 
right hippocampus. 
 
Group-level statistical analyses 
Hippocampal volumetric and metabolite concentration data were compared between 
groups of patients and controls using univariate analyses of covariance (ANCOVA), 
controlling for age, in SPSS Statistics (v22). The normality of subfield volume and 
metabolite data were assessed using Shapiro-Wilk tests for both TLE patients and healthy 
controls. In controls, subfield volumes fit a normal distribution (all p> 0.05). However, in 
TLE patients, right hippocampal CA1 as well as left dentate gyrus and CA1 subfield 
volumes did not meet assumptions of normality. Shapiro-Wilk tests on metabolite 
concentrations were not significant in TLE patients (i.e. met assumptions of normality), 
whereas in controls, right hippocampal total choline measurements deviated from a normal 
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distribution. Individual measures that violated the assumptions of normality were subjected 
to a Box-Cox transformation prior to analysis. Left and right-hemisphere measurements in 
controls were compared using paired-samples t-tests to determine symmetry prior to 
averaging for comparison of patients values according to side of seizure presumed onset 
(ipsilateral / contralateral). Associations between imaging and clinical measures were 
assessed using two-tailed Pearson’s correlation analyses, except for correlations between 
hippocampal subfield volumes and verbal memory scores, since hippocampal volumes in 
TLE patients were always smaller than in healthy controls. Only a positive association 
between reduced volumes and reduced memory performance were therefore expected. 
 
Individual-level statistical analyses 
Individual-level case-control analyses were performed to assess abnormalities in structural 
and metabolite measurements from single patients. Because of the possibility that 
distributions in small control samples might violate the assumptions underlying single-case 
t-test analyses 60, we performed inference testing using permutation methods implemented 
in Permutation Analysis of Linear Models (PALM), part of the FMRIB Software Library 
package (https://fsl.fmrib.ox.ac.uk/fsl/fslwiki/PALM/) 27. Variables of interest (the 5 subfield 
volumes in each hemisphere, the concentrations for our 6 metabolites in each hemisphere, 
and their corresponding asymmetry indices) were submitted as inputs to PALM, and tested 
for every patient separately against distributions built from our group of healthy controls. 
The significance that can be achieved in permutation testing (i.e. 1/n) is fundamentally 
determined by the sample size. For small-sample and single case-control analyses, PALM 
offers a solution to this problem in the form of sign flipping. If we can make assumptions 
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that the residuals of the general linear model are symmetrical around zero, then we can 
randomly ‘flip’ or invert some of the data (making positive values negative), increasing the 
number of possible data shufflings 27. The distributions of certain measures such as 
volume are always positive and skewed. Therefore, we first performed a Box-Cox power 
transformation on the volume and metabolite measurements to satisfy the assumptions of 
the model before submitting these to permutation testing. We report permutation p-values 
for significant results (p < 0.05), uncorrected for multiple comparisons for this first 
description of combined metabolite and subfield volumetric findings. In results Table 1, 
findings that survived family-wise error rate (alpha inflation) correction for the number of 
variables included in each analysis (i.e. up to 5 for subfield asymmetry, up to 6 for 
metabolite asymmetry, up to 10 for individual subfield volumes and up to 12 for 
metabolites) are marked with asterisks. 
 
Data Availability  
The datasets generated and analyzed during the current study are available from the 
corresponding author on reasonable request. 
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Table 1. Patient clinical and demographic data 







AEDs at time of 7T scan icEEG 
findings  














Lamotrigine 200mg mane, 300mg nocte 
Lacosamide 300mg bd 








2 29 7 N Normal Bil (L > R) Levetiracetam 1250mg bd 
Lacosamide 100mg bd 
Topiramate 300mg bd 
Clobazam 10mg prn for clusters  
Bil L TL  - 
 3 37 5 Y LHS  LTLE Levetiracetam 1500mg bd 
Carbamazepine 800mg mane, 1000mg nocte 
Clobazam 10mg prn for clusters (rare) 
- L TL  - 
4 49 19 Y RHS RTLE Phenytoin 600mg bd 
Clonazepam 2mg bd 
Lacosimide 150mg mane, 200mg nocte 
- normal 3a, 4 
5 29 21 N LHS LTLE Topiramate 125mg bd 
Lamotrigine 100mg bd 
Clobazam 10mg nocte 
- - 1a/1a 
6 57 30 Y LHS  LTLE Pregabalin 125 mg mane, 100mg nocte 
Tegretol retard 400mg mane, 600mg nocte 
Topiramate 100mg bd 
Clonazepam  1.5mg nocte 
- - 1a/1a 




8 35 18 N Normal RTLE  Levetiracetam 1500mg bd 
Oxcarbazepine 300mg mane, 300mg midi, 
600mg nocte 
- normal - 
9 37 32 N Normal LTLE  Levetiracetam 1500mg bd 
Lacosamide 200mg bd 
Clobazam 20mg bd 
Carbamazepine 600mg bd 
neocortical normal - 
10* 27 23 N Normal RTLE Carbamazepine 400mg mane, 800mg nocte 
Perampanel 10mg nocte 
Clobazam 20mg nocte 
- Minor R TL 1b/2* 






Levetiracetam 1500mg bd 
 
- Bil (R > L) -  
12 32 3 Y LHS LTLE Levetiracetam 1500mg bd 
Lacosamide 200mg bd 
Oxcarbazepine 900md bd 
- LMTL  - 
Legend. Demographic and clinical data in TLE patients, including age at onset of seizures (in years), presence or absence 
of a febrile convulsion (F/c), results of intracranial depth electrode (icEEG) investigations, surgical outcome for operated 
patients and anti-epileptic drug (AED) regime at the time of the scan. All patients were drug-resistant based on lack of 
response to current and previously tried medications. mg = milligrams. bd = twice daily. Surgical outcomes are reported ≥ 
1 year after surgery, with the exception of Case 10 (asterisk), who was operated 6 months ago. icEEG = intracranial 
electroencephalography (EEG). HS = hippocampal sclerosis. PET = Positron Emission Tomography. Seizure outcomes 
are listed according to both the Engel and International League Against Epilepsy (ILAE) classification schemes.
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Table 2. Individual patient clinical imaging data and 7T findings 
TLE  Age 
Clinical 
MRI 



















R MTL  LCA3, p=0.03 CA2, p=0.04 
(L<R) 
- - 
2‡ 29 Normal Bil (L>R) L TL  LCA3 (p<0.01), 
RCA2 (p=0.05) 
n.s. - - 
 3 37 LHS  LTLE L TL  n.s. n.s. - - 
4| 49 normal RTLE normal n.s. (trends for R 





















7 42 LHS  RTLE Subtle R 
MTL  





























11 19 Normal  RTLE  Bil (R>L) LCA3, p=0.02 n.s. n.s. n.s. 
























Legend. Clinical data in our temporal lobe epilepsy (TLE) patients, presented alongside 
significant permutation test results (p < 0.05, uncorrected) for manually segmented subfield 
volumes and metabolite concentrations in the left and right hippocampus in each patient as 
compared to controls. Values were decreased in patients compared to controls unless 
marked as increased ("inc"). Asterisks (*) identify results that survived family-wise error 
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correction for up to a maximum of 12 variables. The symbol ‡ denotes patients who 
underwent intracranial recordings and | denotes patients who have been operated (see e-
Table 1). SWI = susceptibility-weighted imaging. n.s. = not significant. HS = hippocampal 
sclerosis. vEEG = video electroencephalography. MTL = medial temporal lobe. Glu = 
glutamate, Gln = glutamine, Ins = myo-inositol, tCho = total Choline (GPC + 
phosphocholine), tNAA = total N-acetylaspartate (NAA + NAAG). 
 
Figures 
Figure 1. Group-level 7T hippocampal subfield volumes 
Hippocampal subfield volumes derived from manual segmentation of high-resolution (0.6 × 
0.6 × 0.6 mm) SWI scans acquired at 7T. Individual subfield volumes are presented for 
groups of controls (white bars) and TLE patients (grey bars). When considered as a group, 
TLE patients had reduced left CA3 (F = 6.35, p = 0.021) and left subiculum (F = 4.92, p = 
0.04) subfield volumes compared to healthy controls (a, red asterisks), which did not reach 
significance when patients were considered according to hemisphere of ictal EEG onset 
(b) (only ipsilateral subiculum retained a tendency to reduced volumes in patients: F = 4.2, 
p=0.055). Error bars represent 95% confidence intervals. 
 
Figure 2. Ultra-high field 7T hippocampal subfield volumetry 
a. Ultra-high resolution (0.6 x 0.6 x 0.6mm) 7T hippocampal imaging in a representative 
TLE patient. Slices were angled perpendicular to the long axis of the hippocampus for 
manual subfield segmentations in the coronal plane (b). c. Manually defined subfield 
volumes for CA1, CA2, CA3 and DG as well as calculated asymmetry between the left and 
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right hemisphere, are shown for 4 patients, illustrating the range of individual patient-
control volumetric results. Individual patient values (black diamond) are represented 
overlaid onto the range measured in controls (open circles). Red asterisks mark significant 
differences in volumes / asymmetries of individual patients when compared to the control 
group (permutation tests, p<0.05, uncorrected). Asymmetry in volumes of subfields CA1, 
CA and DG were identified ipsilateral to the side of seizure onset in a patient with 
radiologically evident HS (Case 12). Conversely, normal asymmetry but bilateral 
reductions in subfield volumes were detected in a MRI-negative patient subsequently 
found to have bilateral seizure onset (Case 2). Discordant findings were, however, 
identified in Case 10, who showed marked asymmetry driven by a significant reduction in 
left CA3 subfield volume, contralateral to right-lateralized ictal EEG discharges and right 
medial temporal PET hypometabolism. This patient underwent a right temporal lobectomy 
with good outcome at 6 months (Class 1b). Similarly, in Case 9, significant CA1 asymmetry 
appeared weighted towards the contralateral hemisphere (the raw values of which were 
not significantly different from controls). Video-EEG in this patient was not localizing within 
the left temporal lobe and subsequent intracranial recordings indicated a lateral rather than 
hippocampal seizure onset zone. 
 
Figure 3. 7T hippocampal metabolite concentrations in TLE and controls 
a. Voxel placement of the hippocampal region of interest for MRS acquisitions in an 
example patient, overlaid onto their high-resolution MP2RAGE anatomical image, and 
representative spectral plots from the left and right hippocampus (b). c. At the group-level, 
TLE patients (grey bars) showed reduced tNAA concentrations compared to healthy 
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controls (white bars) both within the hippocampus ipsilateral and contralateral to the side of 
ictal onset (red asterisks, analysis of covariance, ipsilateral F = 6.84, p = 0.018; 
contralateral F = 17.23, p = 0.001). Glutamate is not reported in this hemisphere-clustered 
analysis due to significant asymmetry (precluding data averaging) in healthy controls. 
Example single patient results are depicted in Figure 4. Error bars represent 95% 
confidence intervals. 
 
Figure 4. Hippocampal neurochemical abnormalities in individual patients measured 
with 7T MRS. 
Absolute metabolite concentrations (μmol/g) estimated using MRS at 7 Tesla from the left 
and right hippocampus, separately, in 4 TLE patients with normal clinical imaging. 
Individual patient values (black diamond) are represented overlaid onto the normal range 
measured in our controls (open circles). Red asterisks mark significant differences in 
metabolite concentrations measured in individual patients when compared to the control 
group (permutation tests, p<0.05, uncorrected for multiple comparisons) (Case 4 showed a 
non-significant trend (see Table 1 and main text). While metabolite concentrations 
appeared sensitive to detect hippocampal dysfunction not detected on clinical MRI, there 
was high variability among individual metabolites affected, and no apparent direct link 
between any single metabolite and lateralization of side of seizure onset. 
 
Figure 5. Association between hippocampal subfield volumes and epilepsy 
variables. 
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Volumes of hippocampal subfields, especially CA1 and the dentate gyrus in the 
hemisphere of seizure onset showed significant associations with epilepsy-related factors 
including age at onset of habitual seizures (a) and duration of epilepsy (b) (Pearson’s two-
tailed correlations). As expected, longer disease duration and earlier age at onset of 
habitual seizures were both associated with smaller hippocampal subfield volumes. 
 
 
Figure 6. Associations between 7T volumetry, MRS and memory performance. 
Both volumes of the subiculum hippocampal subfield (a) and overall hippocampal 
metabolite concentrations (b) showed significant relationships to clinical 
neuropsychological tests measures of verbal memory performance in TLE patients. 
Reduced volume of the subiculum in the language-dominant hemisphere correlated with 
lower delayed story recall (Pearson’s one-tailed correlation), while reduced left 
hippocampal glutamine concentrations were associated with lower list learning (Pearson’s 
two-tailed correlation). Significant memory impairment in patients is defined as a test z-
score of -1.34 or lower. 






